MARKET

VNRX

VNRX

VOLITIONRX
AMEX

Real-time Quotes | Nasdaq Last Sale

5.50
+0.08
+1.48%
Closed 16:00 11/11 EST
OPEN
5.42
PREV CLOSE
5.42
HIGH
5.55
LOW
5.32
VOLUME
102.51K
TURNOVER
--
52 WEEK HIGH
6.84
52 WEEK LOW
1.670
MARKET CAP
225.99M
P/E (TTM)
-11.4416
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VNRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VNRX News

  • VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update
  • PR Newswire.4d ago
  • Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
  • PR Newswire.10/29 13:30
  • VolitonRx Reports Further $500K Non-Dilutive Funding In Form Of Loan From Texas A&M SOFINEX Funding Agency to Support Development Of volition Veterinary Diagnostics Development
  • Benzinga.10/29 12:36
  • Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
  • PR Newswire.10/25 17:00

More

Industry

Medical Equipment, Supplies & Distribution
-0.11%
Healthcare Equipment & Supplies
+0.01%

Hot Stocks

Name
Price
%Change

About VNRX

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
More

Webull offers VolitionRX Ltd (VNRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.